Association of expression of leucine-rich repeats and immunoglobulin-like domains 2 gene with invasiveness of pituitary adenoma

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 31, Issue 4, 2011, Pages 520-523

  Zhang, Huaqiu ^a   Yan, Qin ^a   Xu, Shutian ^a   Ou, Yibo ^a   Ye, Fei ^a   Wang, Baofeng ^a   Lei, Ting ^a   Guo, Dongsheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Invasiveness; LRIG2; Pituitary adenoma

Indexed keywords

LRIG2 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ADENOMA; ARTICLE; GENE EXPRESSION; GENETICS; HUMAN; HYPOPHYSIS TUMOR; PATHOLOGY; TUMOR INVASION;

ADENOMA; GENE EXPRESSION; HUMANS; MEMBRANE GLYCOPROTEINS; NEOPLASM INVASIVENESS; PITUITARY NEOPLASMS;

EID: 80455137083     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-011-0483-3     Document Type: Article

References (25)

1. Hashimoto N, Handa H, Yamashita J, et al. Long-term follow-up of large or invasive pituitary adenoma. Surg Neurol, 1986,25(1):49-54 (Pubitemid 16178525)
2. Goel A, Nadkarni T, Muzumdar D, et al. Giant pituitary tumors: a study based on surgical treatment of 118 cases. Surg Neurol, 2004,61(5):436-445 (Pubitemid 38543084)
3. Nilsson J, Vallbo C, Guo D, et al. Cloning, characterization, and expression of human LIG1. Biochem Biophys Res Commun, 2001,284(5):1155-1161 (Pubitemid 32917959)
4. Guo D, Holmlund C, Henriksson R, et al. The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea. Genomics, 2004,84(1):157-165 (Pubitemid 38760139)
5. Hedman H, Nilsson J, Guo D, et al. Is LRIG1 a tumor suppressor gene at chromosome 3p14.3? Acta Oncol, 2002,41(4):352-354
6. Yang WM, Yan ZJ, Ye ZQ, et al. LRIG1, a candidate tumor-suppressor gene in human bladder cancer cell line BIU87. BJU Int, 2006,98(4):898-902
7. Hedman H, Henriksson R. LRIG inhibitors of growth factor signalling - double-edged swords in human cancer? Eur J Cancer, 2007,43(4):676-682 (Pubitemid 46502902)
8. Wang B, Han L, Chen R, et al. Downregulation of LRIG2 expression by RNA interference inhibits glioblastoma cell (GL15) growth, causes cell cycle redistribution, increases cell apoptosis and enhances cell adhesion and invasion in vitro. Cancer Biol Ther, 2009,8(11):1018-1023
9. Cai M, Han L, Chen R, et al. Inhibition of LRIG3 gene expression via RNA interference modulates the proliferation, cell cycle, cell apoptosis, adhesion and invasion of glioblastoma cell (GL15). Cancer Lett, 2009,278(1): 104-112
10. Guo D, Han L, Shu K, et al. Down-regulation of leucine- rich repeats and immunoglobulin-like domain proteins (LRIG1-3) in HP75 pituitary adenoma cell line. J Huazhong Univ Sci Technolog Med Sci, 2007,27(1): 91-94
11. Scheithauer BW, Kovacs KT, Laws ER Jr, et al. Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg, 1986,65(6):733-744 (Pubitemid 17187407)
12. Oruckaptan HH, Senmevsim O, Ozcan OE, et al. Pituitary adenomas: results of 684 surgically treated patients and review of the literature. Surg Neurol, 2000,53(3): 211-219 (Pubitemid 30201524)
13. Onguru O, Scheithauer BW, Kovacs K, et al. Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomas. Mod Pathol, 2004, 17:772-780 (Pubitemid 38843359)
14. Theodoropoulou M, Arzberger T, Gruebler Y, et al. Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells. J Endocrinol, 2004,183(2):385-394 (Pubitemid 39562718)
15. Chaidarun SS, Eggo MC, Sheppard MC, et al. Expression of epidermal growth factor (EGF), its receptor, and related oncoprotein (erbB-2) in human pituitary tumors and response to EGF in vitro. Endocrinology, 1994,135(5): 2012-2021 (Pubitemid 24363897)
16. Musacchio M, Perrimon N. The Drosophila kekkon genes: novel members of both the leucine-rich repeat and immunoglobulin superfamilies expressed in the CNS. Dev Biol, 1996,178(1):63-76 (Pubitemid 26297240)
17. Ghiglione C, Carraway KL 3rd, Amundadottir LT, et al. The transmembrane molecule kekkon 1 acts in a feedback loop to negatively regulate the activity of the Drosophila EGF receptor during oogenesis. Cell, 1999,96(6):847-856 (Pubitemid 29165087)
18. Guo D, Nilsson J, Haapasalo H, et al. Perinuclear leucine- rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors. Acta Neuropathol, 2006, 111(3):238-246
19. Laederich MB, Funes-Duran M, Yen L, et al. The leucinerich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases. J Biol Chem, 2004, 279(45):47050-47056 (Pubitemid 39518360)
20. Shattuck DL, Miller JK, Laederich M, et al. LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy. Mol Cell Biol, 2007,27(5): 1934-1946.
21. Ledda F, Bieraugel O, Fard SS, et al. Lrig1 is an endogenous inhibitor of Ret receptor tyrosine kinase activation, downstream signaling, and biological responses to GDNF. J Neurosci, 2008,28(1):39-49
22. Hedman H, Lindström AK, Tot T, et al. LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix. Acta Oncol, 2010,49(6):812-815
23. Holmlund C, Nilsson J, Guo D. Characterization and tissue-specific expression of human LRIG2. Gene, 2004, 33(2):35-43 (Pubitemid 38624248)
24. Holmlund C, Haapasalo H, Yi W, et al. Cytoplasmic LRIG2 expression is associated with poor oligodendrog lioma patient survival. Neuropathology, 2009,29(3):242-247
25. Eisenstat DD, Gibson SB. RIGging functional outcomes in glioma cells: new insights into LRIG proteins in malignant gliomas. Cancer Biol Ther, 2009,8(11):1024-1026.